Board of Directors
Andrew A. Dahl
President / Chief Executive Officer & Director
Mr. Dahl was formerly a principal consultant and managing director of Great Northern & Reserve Partners, LLC, a marketing strategy and business planning consultancy focused on the biomed and biotech sectors, since 2005. For the previous 20 years, Mr. Dahl served as President of Dawber & Company, Inc., one of the largest independent marketing & consulting firms in the Midwest, with an extensive Fortune 500 client roster that included GM, Ford, Northwest, Xerox, AT&T and Compuware, among others. He attended the College for Creative Studies and Wayne State University. Mr. Dahl holds three US patents for interactive multimedia and is a named inventor in one recent biotech patent and several biomed patent applications.
Alison A. Cornell
Director since 2021
Ms. Cornell currently serves as the Executive Vice President & Chief Financial Officer of Compassion-First Pet Hospitals, and has held such office since July 2017. Previously, she served as Executive Vice President & Chief Financial Officer of International Flavors & Fragrances Inc. (NYSE: IFF, Euronext Paris: IFF) from July 2015 through October 2016, and before that, she served multiple roles at Covance, Inc. (NYSE: CVD) from 2004 through July 2015, including Corporate Senior Vice President & Chief Financial Officer.
Director since 2013
Mr. Maggiore was appointed to the Board of Directors on August 28, 2013. He has a successful track record in entrepreneurship, with over 25 years of experience in the areas of real estate development and building and management of businesses. Mr. Maggiore currently owns and manages a portfolio of diverse businesses and investments.
Nola E. Masterson
Director since 2014
Ms. Masterson has an extensive and well-regarded track record in the biotech industry and has 33 years of experience in the life science industry. Ms. Masterson is the Chair Emeritus of the Bay Bio Institute, a 501(c)3 affiliate of BayBio. Since 1982, she has been the Chief Executive Officer of Science Futures Inc., an investment and advisory firm, and is currently Managing Member and General Partner of Science Futures LLC, I and II, which are venture capital funds invested in life science funds and companies. She received her Masters’ degree in Biological Sciences from George Washington University and continued Ph.D. coursework at the University of Florida.
John B. Payne
Director since 2013
Mr. Payne brings more than 30 years’ experience in the global animal health industry to the ZIVO board of directors. Mr. Payne is a board member and officer of the American Humane Association and CEO of Compassion First Pet Hospitals, having previously served as President and CEO of Banfield Pet Hospitals, and a leadership team member for Mars Global PetCare. Mr. Payne also served as President and General Manager of Bayer Healthcare's North American Animal Health Division. He has been honored for his commitment to bringing “human quality” medicine and healthcare to pets, and has gained worldwide recognition for his achievements.
Robert O. Rondeau, Jr.
Director since 2016
Mr. Rondeau brings years of experience in finance and lending to the Board of Directors. As chief executive officer of PRZ, LLC, a financing company Mr. Rondeau has focused on inventory financing, retail financing and leasing, a position he has held since 2013. Mr. Rondeau is also the chief executive officer of Bran Financial, a credit card processing company, a position he has held since 2010. Prior to that, Mr. Rondeau was an executive director of Flagstar Bank, focusing on commercial, consumer and warehouse lending from 2004 through 2009, and President of Flagstar Bank’s title insurance subsidiary. Mr. Rondeau received a Bachelor of Arts degree from Northwestern University and an Executive M.B.A. from Michigan State University.